Filing

Perspective Therapeutics, Inc. Filed 2025-03-26 Acc 0000950170-25-045209

Documents 1

2025-04-01 4 Chief Executive Officer bought 26,676 shares at an average $2.24 ($59,673)
2025-03-28 10-K/A 10-K/A
2025-03-26 POS AM Post-effective Amendment for Registration Statement
2025-03-26 S-8 Securities Offered to Employees in Benefit Plans
2025-03-26 10-K Annual Report
2025-03-26 8-K Results of operations · Other events
2025-03-26 POSASR POSASR

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading posasr_1_-_march_2025.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…